Human Papillomavirus Recombinant Vaccine from China
VLP vaccine from HPV L1 protein expression for cervical cancer prevention. Classified HTS 3002.49.0050 as other viral biotechnological product.
Duty Rate — China → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• List HPV types covered; 2-8°C with monitoring
• Pediatric/adult labeling; post-marketing commitment docs
• Bulk antigen to 3504 if unfinished